BidaskClub upgraded shares of NantHealth Inc (NYSE:NH) from a strong sell rating to a sell rating in a research note published on Friday.
A number of other equities analysts have also weighed in on the stock. Jefferies Group LLC restated a buy rating and set a $5.50 target price (down previously from $8.00) on shares of NantHealth in a research report on Monday, June 19th. Canaccord Genuity restated a buy rating and set a $6.00 target price (down previously from $8.00) on shares of NantHealth in a research report on Monday, August 21st. One research analyst has rated the stock with a sell rating and five have given a buy rating to the stock. The stock has a consensus rating of Buy and an average target price of $8.55.
Shares of NantHealth (NYSE NH) opened at 4.12 on Friday. The stock’s 50 day moving average is $3.60 and its 200-day moving average is $4.13. NantHealth has a 12-month low of $2.60 and a 12-month high of $15.80. The company’s market capitalization is $502.42 million.
NantHealth (NYSE:NH) last issued its earnings results on Thursday, August 10th. The company reported ($0.58) earnings per share for the quarter, missing the Zacks’ consensus estimate of ($0.26) by $0.32. NantHealth had a negative return on equity of 83.97% and a negative net margin of 267.11%. The company had revenue of $26.23 million for the quarter, compared to the consensus estimate of $31.28 million. During the same quarter in the prior year, the company posted ($0.15) EPS. NantHealth’s revenue was down 16.7% compared to the same quarter last year. Analysts anticipate that NantHealth will post ($0.70) earnings per share for the current year.
A number of hedge funds have recently added to or reduced their stakes in the business. TIAA CREF Investment Management LLC lifted its position in NantHealth by 68.6% during the first quarter. TIAA CREF Investment Management LLC now owns 20,200 shares of the company’s stock valued at $100,000 after purchasing an additional 8,217 shares during the last quarter. California State Teachers Retirement System lifted its position in NantHealth by 132.4% during the second quarter. California State Teachers Retirement System now owns 31,600 shares of the company’s stock valued at $134,000 after purchasing an additional 18,000 shares during the last quarter. Bank of America Corp DE lifted its position in NantHealth by 366.4% during the first quarter. Bank of America Corp DE now owns 25,069 shares of the company’s stock valued at $125,000 after purchasing an additional 19,694 shares during the last quarter. Alliancebernstein L.P. bought a new position in NantHealth during the second quarter valued at $102,000. Finally, Teachers Advisors LLC lifted its position in NantHealth by 351.8% during the second quarter. Teachers Advisors LLC now owns 31,578 shares of the company’s stock valued at $134,000 after purchasing an additional 24,588 shares during the last quarter.
NantHealth Company Profile
NantHealth, Inc is a healthcare cloud-based information technology (IT) company. The Company is engaged in converging science and technology through a single integrated clinical platform, to provide actionable health information at the point of care. The Company offers the Genomic Proteomic Spectrometry (GPS) Cancer test, a molecular test and decision support solution that measures the proteins present in the patient’s tumor tissue, combined with whole genomic and transcriptomic sequencing of tumor and normal samples.
Receive News & Ratings for NantHealth Inc Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for NantHealth Inc and related companies with MarketBeat.com's FREE daily email newsletter.